Sun shines on Dyesol with $1.4 million boost

Published 25-AUG-2016 15:02 P.M.


2 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.

Click Here to View Latest Articles

Perovskite solar hopeful Dyesol (ASX:DYE) has managed to bag a cash boost – awarded £800,000 ($A1.4 million) from a UK agency.

Dyesol told its shareholders this morning that it had managed to bag the cash from the Engineering and Physical Sciences Research Council, for joint research between DYE and Cristal, and the University of York into oxide films.

In particular, the trio have been working on an oxide film which can be applied to DYE’s perovskite solar cells which could potentially provide a performance uplift.

The company said that in early experiments, the film the trio had created translated into a 2-3% uplift in conversion efficiency – and therefore considered a vital component in the industrialisation of DYE’s technology.

With the cash, the trio will try to better understand the chemical reaction happening inside the film, and how to apply it to larger surface areas – potentially opening the way for even greater energy conversion in the future.

It warned that it was still early days though, so investors should not expect a 2-3% efficiency gain straight out of the gate. Always consult a professional financial advisor before investing.

Dyesol and Cristal have recently filed a provisional patent to begin commercial protection of its work.

About Dyesol

Dyesol is a renewable energy supplier and leader in Perovskite Solar Cell technology – 3rd generation photovoltaic technology that can be applied to glass, metal, polymers or cement.

Dyesol manufactures and supplies high performance materials and is focused on the successful commercialisation of PSC photovoltaics.

Perovskites in general is starting to be thought about more in the solar cell space, as it is easier to manufacture and are more adaptable than stock-standard solar cells.

Perovskites are a wide-ranging class of materials in which organic molecules made mostly of carbon and hydrogen bind with a metal such as lead and a halogen such as chlorine in a three-dimensional crystal lattice.

Manufacturers can mix up batches of liquid solutions and then deposit the perovskites as thin films on surfaces of virtually any shape, as the film weighs very little.

General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.


Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free